Peptide dosage chart.

Turning a dose into syringe units.

A dose in micrograms is not a mark on a syringe. The conversion depends on vial size and how much bacteriostatic water went in, which is arithmetic rather than clinical judgment. Klarovel keeps that arithmetic in dedicated tools instead of repeating it here.

What this table does not publish.

Nothing, at present. Every peptide in the Klarovel catalog that appears in protocols now has a sourced starting dose and upper bound, so the table is complete. That was not true earlier: three compounds sat here as gaps because this page read only the research catalog, while the engine dose table held full figures for all three. If a compound is ever added without sourced figures it will be named here with the reason, because publishing an inferred number would be worse than publishing nothing.

Where a personal dose comes from.

A reference range is not a protocol. Klarovel's rules engine narrows the range using a health questionnaire: contraindications first, then experience tier, then body weight for the compounds where dosing scales with mass, then age caps. Blood work sharpens the result when a person has it, and changes nothing about whether they can get a protocol at all.

The engine also refuses. Pregnancy blocks growth hormone peptides outright. A cancer history blocks the pro-angiogenic compounds. Research suggests several of these interactions are dose independent, so the engine treats them as exclusions rather than reductions.

Klarovel builds the protocol. It does not sell, supply, or ship peptides. Fulfilment sits with partner suppliers, and that separation is set out in the disclosures.

Frequently asked questions about peptide dosage.

What is a standard peptide dose?

There is no single standard. Each peptide has its own range, and the table on this page lists a starting dose and an upper bound per compound. The starting dose is the conservative entry point; the upper bound is the ceiling the Klarovel engine will not exceed when it builds a protocol. Where a person lands between the two depends on their health data, their goals, and their experience with injectable peptides.

How is a peptide dose actually decided?

Klarovel's rules engine starts from the health questionnaire, then applies contraindication checks, experience tier, body weight where the peptide is weight sensitive, and age caps. Blood work is optional. It refines the result when it is available, but a protocol is built from health data and never blocked on a lab panel.

Do peptides need to be cycled?

Most in this reference do. The cycle column shows weeks on and weeks off for each compound. GLP-1 receptor agonists are the exception: semaglutide, tirzepatide, and retatrutide are continuous-use, because stopping is associated with weight regain in the published trial data.

Where do these dose figures come from?

Three sources, in order. GLP-1 receptor agonists use their label-driven titration ladder. Everything else uses the Klarovel engine dose table, which is the same table the engine doses from and the dose guard caps against. Where that table has no row, the older research catalog is the fallback. No figure on this page is typed by hand, and any compound with no sourced figure in any of the three is named further down the page rather than given an inferred number.

How do I convert a dose into syringe units?

Use the Klarovel peptide reconstitution calculator. It takes vial size, bacteriostatic water volume, and target dose, and returns the exact units to draw. That conversion is arithmetic, not clinical judgment, so a calculator is the right tool for it.

Are these doses a prescription?

No. This page is a reference for what the Klarovel dose catalog supports. It is educational, not medical advice, and it is not a recommendation to use any compound. Peptide use should be discussed with a qualified clinician.